Connection
Maki Nakayama to Histocompatibility Antigens
This is a "connection" page, showing publications Maki Nakayama has written about Histocompatibility Antigens.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.428 |
|
|
|
-
Nakayama M, Michels AW. Using the T Cell Receptor as a Biomarker in Type 1 Diabetes. Front Immunol. 2021; 12:777788.
Score: 0.188
-
Slansky JE, Nakayama M. Peptide mimotopes alter T cell function in cancer and autoimmunity. Semin Immunol. 2020 02; 47:101395.
Score: 0.168
-
Zhang L, Gianani R, Nakayama M, Liu E, Kobayashi M, Baschal E, Yu L, Babu S, Dawson A, Johnson K, Jahromi M, Aly T, Fain P, Barker J, Rewers M, Eisenbarth GS. Type 1 diabetes: chronic progressive autoimmune disease. Novartis Found Symp. 2008; 292:85-94; discussion 94-8, 122-9, 202-3.
Score: 0.072